title: Granulocyte colony stimulating factor-induced tumor lysis-like syndrome: leucolysis.
authors.affiliation: Department of Medical Oncology, Hacettepe University Institute of Oncology, Ankara, Turkey.
authors.forename: T
authors.initials: T
authors.lastname: Babacan
authors.forename: F
authors.initials: F
authors.lastname: Sarici
authors.forename: A
authors.initials: A
authors.lastname: Gokhan
authors.forename: O
authors.initials: O
authors.lastname: Balakan
authors.forename: O
authors.initials: O
authors.lastname: Keskin
authors.forename: K
authors.initials: K
authors.lastname: Altundag
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects*; D017809:Fatal Outcome; D000069585:Filgrastim; D016179:Granulocyte Colony-Stimulating Factor / Q000009:adverse effects*; D006801:Humans; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D011994:Recombinant Proteins / Q000009:adverse effects; D015275:Tumor Lysis Syndrome / Q000209:etiology*
chemical_list: D000970:Antineoplastic Agents; D011994:Recombinant Proteins; D016179:Granulocyte Colony-Stimulating Factor; D000069585:Filgrastim